Manufacturer: Cipla, India
Pharmaceutical name: Bosentan
Pack: 1 pack (20 pills (125 mg))
Bosentas is utilized in the management of pulmonary hypertension (elevated pressure in the blood vessels of the lungs). It works by relaxing the lung blood vessels, leading to a reduction in blood pressure. Bosentas acts as an endothelin receptor antagonist and is prescribed for pulmonary arterial hypertension (high blood pressure in the lungs). It inhibits the effects of endothelin-1, which decreases pulmonary blood pressure. Additionally, Bosentas helps prevent the thickening of blood vessels.
Bosentas is indicated for the treatment of pulmonary arterial hypertension (PAH). It enhances exercise capacity and helps prevent the progression of the condition.
Common side effects include: fever, flu-like symptoms, swollen lymph nodes, fatigue; facial swelling; a red or blistering rash, severe tingling or numb sensations; cough, chest discomfort, breathing difficulties; weight loss; or pain or burning during urination, lower back pain, and swelling in the legs or feet.
This does not represent a comprehensive list of all potential side effects. If you have inquiries regarding side effects, consult your healthcare provider.
Avoid using Bosentas if you are pregnant or suspect you might be pregnant, as it can lead to serious liver complications. Regular liver function tests will be necessary.
Certain medications may interact with Bosentas and should not be taken simultaneously. Ensure your doctor is informed about all medications you are currently taking.
It remains unclear whether Bosentas can pass into breast milk or pose risks to a breastfeeding infant. Therefore, nursing while on Bosentas is not advised.
Bosentas blocks a substance in the blood that causes constriction of blood vessels. It is available as a tablet for oral intake, with or without food. The recommended dosage is 62.5 mg twice daily for 4 weeks, followed by a maintenance dose of 125 mg twice daily.